Pharma Performance Assessments  

OTC Positioning

Prior to market entry, XSIGHTS was commissioned to carry out a survey on the over-the-counter (OTC) category by a large pharmaceutical company to position a new product in a crowded market, gaining significant market shares in the first six months.

Pharma Detailing Role- Play

In this research, experienced medical representatives performed a live presentation in front of physicians, who then evaluated representatives’ performances and the choice of words in the text.  At the end of the research our client was able to align its detailing with its global positioning as a knowledge leader. The results of this work significantly increased the firm’s sales performance.

Bayer Pharmaceuticals Pandemic Presentation Research, 2021

Bayer commissioned XSIGHTS to conduct a quantitative study to examine the impact of the COVID-19 pandemic on healthcare professionals in Turkey and to develop appropriate action plans. The research included interviews with Bayer-served specialists in various medical fields including cardiology, gynecology, ophthalmology, oncology and hematology. XSIGHTS interviewed 370 physicians in these seven specialties via CATI (Computer-Assisted Telephone Interviewing) and online methods to understand how they were affected by the pandemic. The survey covered topics such as patient loads, treatment distribution, communication with patients, communication with pharmaceutical companies and support received from the pharmaceutical sector. The findings were used to draw the new strategy for field visits during and after COVID-19.    

Message Recall Research

Japanese pharmaceutical company, Daiichi Sankyo, commissioned XSIGHTS to carry out market research to measure the level of recall by 1,500 Turkish cardiologists who had been visited by Daiichi Sankyo representatives about the drug Lixiana in 2020 and 2021. The research aimed to assess both the recall of representative visits among physicians and the retention of messages conveyed during those visits. XSIGHTS conducted quantitative hybrid interviews (combining face-to-face and CATI methods) with 280 physicians across four cities. The data obtained helped Daiichi Sankyo to assess the performance of sales representatives.

Hematology Research

XSIGHTS carried out quantitative market research for Bayer’s Hematology Division. The purpose was to understand the patient load of Turkish hematologists. The survey also examined the level of knowledge about treatment alternatives, treatment preferences, dosage and frequency decisions, as well as expectations regarding the introduction of Hemlibra and EHL products to the market. The results were used to plan communications and visiting strategy in 2020.

OTC Brand Awareness Research

XSIGHTS was hired by a local pharmaceutical company in Turkey to carry out research on the awareness and positioning of an international pharmaceutical company’s over-the-counter (OTC) multivitamin/mineral brand among consumers and pharmacists in Turkey.  The research findings provided guidance for the company’s strategic plans and decision-making aimed at increasing market share in a very competitive market.

Polifarma Customer Satisfaction Research

A regular study is carried out on behalf of Polifarma, a large European pharmaceutical company with operations in Turkey. The study measures the satisfaction of healthcare professionals, purchasing managers and pharmacists visited by Polifarma and its competitors. The insights obtained are widely used for the implementation of action points for strategic decision making. XSIGHTS conducts this survey on a regular basis and is able to track progress since 2018.